Management of Emphysema

Immediate Smoking Cessation Strategy

The American Thoracic Society recommends smoking cessation as the absolute priority and the only intervention proven to slow disease progression, reduce mortality, and improve outcomes in emphysema, which must be addressed immediately with combination pharmacotherapy (varenicline or bupropion PLUS nicotine replacement therapy) alongside intensive behavioral counseling 1, 2
Smoking cessation is the only treatment that modifies the natural decline in lung function in COPD, and when smokers quit, their subsequent lung function decline returns to rates similar to healthy non-smokers 4, 1
The American College of Chest Physicians recommends abrupt cessation rather than gradual reduction, as gradual withdrawal rarely achieves complete cessation 3

The American Thoracic Society recommends initiating inhaled bronchodilator therapy immediately to reduce symptoms, prevent exacerbations, and improve exercise tolerance, starting with either a long-acting β2-agonist (LABA) or long-acting anticholinergic (LAMA like tiotropium) 1, 2, 6
Pharmacologic therapy reduces COPD symptoms, decreases frequency and severity of exacerbations, and improves health status and exercise tolerance 1, 2

The American Thoracic Society recommends administering influenza vaccine annually to reduce serious illness, death, risk of ischemic heart disease, and total exacerbations 1, 2
The Centers for Disease Control and Prevention recommends pneumococcal vaccines (PCV13 and PPSV23) for all patients 65 years and older, and this patient at 61 should receive them given emphysema 1, 2

The American Thoracic Society recommends referring to pulmonary rehabilitation program to improve symptoms, quality of life, and physical and emotional participation in everyday activities, with benefits occurring regardless of disease severity 1, 2

The American Thoracic Society recommends evaluating for hypoxemia and severe airflow limitation to determine if additional life-prolonging therapies are needed, checking arterial blood gas or pulse oximetry at rest, and performing spirometry to assess severity 1, 2, 6
Long-term oxygen therapy is the only treatment besides smoking cessation known to improve prognosis in patients with severe COPD and hypoxemia, with a target oxygen saturation of 88-92% if respiratory acidosis develops 4, 6

The American Heart Association recommends assessing for cardiovascular disease, as approximately 26% of deaths in moderate to severe COPD are cardiovascular, and addressing cardiovascular risk factors aggressively as COPD and CVD share common pathobiological pathways 6

The American Thoracic Society recommends scheduling close follow-up within 2-4 weeks to assess smoking cessation progress and symptom response, performing spirometry regularly to monitor disease progression, and reassessing inhaler technique at each visit 3, 1, 2